Various pharmaceutical shortage items; including, but not limited to, blood products such as: carimune; oncological pharmaceuticals such as: vinblastine, novoseven and other relevant pharmaceuticals…
Ended Awarded
- Contract number
- HT001418F0278
- Awardee
-
Broughton Pharmaceuticals, LLC UEI J949HUF889Y1
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $250,000
Award facts
- Contract value 100% obligated
- $250,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
About this award
This contract was awarded by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, GA. The $250,000 Blanket Purchase Agreement (BPA) call contract is for the provision of various pharmaceutical shortage items, including blood products, oncological pharmaceuticals, and other injectable, oral, and inhalation medications. The contract has a completion date of September 30, 2018 and uses a firm fixed price pricing type. Broughton Pharmaceuticals has experience providing a range of medical products, including shortage drugs and COVID-19 related supplies, to federal agencies such as the Department of Veterans Affairs (VA), the Indian Health Service, and Walter Reed National Military Medical Center. This BPA call is likely part of a larger $2 million single-award BPA that Broughton Pharmaceuticals holds with the DHA to provide pharmaceutical products as needed at DHA medical facilities.
Description
Various pharmaceutical shortage items; including, but not limited to, blood products such as: carimune; oncological pharmaceuticals such as: vinblastine, novoseven and other relevant pharmaceuticals products including injectables, orals and medicinal inhalations
Quick answers
Who was awarded contract HT001418F0278?
HT001418F0278 was awarded to Broughton Pharmaceuticals, LLC by Defense Health Agency (Department of Defense) on June 26, 2018.
How much is contract HT001418F0278 worth?
The government has obligated $250,000 on HT001418F0278.
Is contract HT001418F0278 an order under another contract?
Yes. HT001418F0278 is a BPA call under HT001414A0014, a blanket purchase agreement.
Was contract HT001418F0278 competed?
The extent of competition for HT001418F0278 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award